miR-214 promotes radioresistance in human ovarian cancer cells by targeting PETN

被引:30
作者
Zhang, Qin [1 ]
Zhang, Shuxiang [1 ]
机构
[1] First Peoples Hosp Jining, Dept Oncol, Jining 272011, Shandong, Peoples R China
关键词
TUMOR PROGRESSION; MICRORNAS; SUPPRESSION; GROWTH; PTEN; RADIOTHERAPY; CARCINOMA; ANTIGENS; PATHWAY;
D O I
10.1042/BSR20170327
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ovarian cancer is one of the leading causes of death among gynecological malignancies. Increasing evidence indicate that dysregulation of microRNAs (miRNAs) plays an important role in tumor radioresistance. The aim of the present study is to investigate whether microRNA-214 (miR-214) was involved in radioresistance of human ovarian cancer. Here, we showed that miR-214 was significantly up-regulated in ovarian cancer tissues and radioresistance ovarian cancer cell lines. Transfection of miR-214 agomir in radiosensitive ovarian cancer cell lines promoted them for resistance to ionizing radiation, whereas transfection of miR-214 antagomir in radioresistance ovarian cancer cell lines sensitized them to ionizing radiation again. Furthermore, we found miR-214 effectively promoted tumor radioresistance in xenograft animal experiment. Western blotting and quantitative real-time PCR demonstrated that miR-214 negatively regulated PTEN in radioresistance ovarian cancer cell lines and ovarian cancer tissues. Taken together, our data conclude that miR-214 contributes to radioresistance of ovarian cancer by directly targeting PTEN.
引用
收藏
页数:8
相关论文
共 39 条
[1]   Relapsed ovarian cancer: Challenges and management strategies for a chronic disease [J].
Armstrong, DK .
ONCOLOGIST, 2002, 7 :20-28
[2]   Application of MicroRNA in Diagnosis and Treatment of Ovarian Cancer [J].
Banno, Kouji ;
Yanokura, Megumi ;
Iida, Miho ;
Adachi, Masataka ;
Nakamura, Kanako ;
Nogami, Yuya ;
Umene, Kiyoko ;
Masuda, Kenta ;
Kisu, Iori ;
Nomura, Hiroyuki ;
Kataoka, Fumio ;
Tominaga, Eiichiro ;
Aoki, Daisuke .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[3]   Cancer of the ovary [J].
Cannistra, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24) :2519-2529
[4]   PTEN and the PI3-Kinase Pathway in Cancer [J].
Chalhoub, Nader ;
Baker, Suzanne J. .
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2009, 4 :127-150
[5]   p53-dependent radioresistance in ovarian carcinoma cell lines [J].
Concin, N ;
Zeillinger, C ;
Stimpfel, M ;
Schiebel, I ;
Tong, D ;
Wolff, U ;
Reiner, A ;
Leodolter, S ;
Zeillinger, R .
CANCER LETTERS, 2000, 150 (02) :191-199
[6]   The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies [J].
Corsini, Lidia Rita ;
Bronte, Giuseppe ;
Terrasi, Marianna ;
Amodeo, Valeria ;
Fanale, Daniele ;
Fiorentino, Eugenio ;
Cicero, Giuseppe ;
Bazan, Viviana ;
Russo, Antonio .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 :S103-S109
[7]  
Fuchs HE., 2021, CA-CANCER J CLIN, V71, P7, DOI [10.3322/caac.21654, DOI 10.3322/caac.20073, DOI 10.3322/CAAC.21332]
[8]   Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients [J].
Gagnon, Audrey ;
Kim, Jae-Hoon ;
Schorge, John O. ;
Ye, Bin ;
Liu, Brian ;
Hasselblatt, Kathleen ;
Welch, William R. ;
Bandera, Christina A. ;
Mok, Samuel C. .
CLINICAL CANCER RESEARCH, 2008, 14 (03) :764-771
[9]   MicroRNAs in Cancer [J].
Lee, Yong Sun ;
Dutta, Anindya .
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2009, 4 :199-227
[10]   Micrornas: Small RNAs with a big role in gene regulation [J].
He, L ;
Hannon, GJ .
NATURE REVIEWS GENETICS, 2004, 5 (07) :522-531